BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18667318)

  • 1. CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.
    Yang DF; Qiu WH; Zhu HF; Lei P; Wen X; Dai H; Zhou W; Shen GX
    Transpl Immunol; 2008 Jul; 19(3-4):197-201. PubMed ID: 18667318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 gene modified dendritic cells inhibit T helper type 1-mediated alloimmune responses and promote immunological tolerance in diabetes.
    Zhu H; Qiu W; Lei P; Zhou W; Wen X; He F; Li L; Dai H; Shen G; Gong F
    Cell Mol Immunol; 2008 Feb; 5(1):41-6. PubMed ID: 18318993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
    Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Uede T; Monden M; Miyasaka M
    Diabetologia; 2002 Jun; 45(6):831-40. PubMed ID: 12107727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCs sensitized with mPD-L1-Ig fusion protein improve the effect of heart transplantation in mice by promoting the generation of T-reg cells.
    Liu C; Chen H; Jia J; Hong T; Wang C
    Cell Immunol; 2014 Jul; 290(1):169-77. PubMed ID: 24997656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival.
    O'Rourke RW; Kang SM; Lower JA; Feng S; Ascher NL; Baekkeskov S; Stock PG
    Transplantation; 2000 Apr; 69(7):1440-6. PubMed ID: 10798768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
    J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1 to Th2 immune deviation facilitates, but does not cause, islet allograft tolerance in mice.
    Zhang D; Sanchez-Fueyo A; Kawamoto K; Alexopoulos SP; Zhang W; Zheng XX
    Cytokine; 2010 Sep; 51(3):311-9. PubMed ID: 20598563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
    Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
    Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.
    Stepkowski SM; Phan T; Zhang H; Bilinski S; Kloc M; Qi Y; Katz SM; Rutzky LP
    Transplantation; 2006 Dec; 82(12):1756-63. PubMed ID: 17198272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].
    Zhang J; Chen GH; Weng JP; Lu MQ; Yang Y; Cai CJ; Xu C; Li H
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):136-9. PubMed ID: 18509975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance.
    Watanabe M; Yamashita K; Kamachi H; Kuraya D; Koshizuka Y; Shibasaki S; Asahi Y; Ono H; Emoto S; Ogura M; Yoshida T; Ozaki M; Umezawa K; Matsushita M; Todo S
    Transplantation; 2013 Sep; 96(5):454-62. PubMed ID: 23860082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
    Steurer W; Nickerson PW; Steele AW; Steiger J; Zheng XX; Strom TB
    J Immunol; 1995 Aug; 155(3):1165-74. PubMed ID: 7543517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
    Li ZL; Xue WJ; Tian PX; Ding XM; Tian XH; Feng XS; Hou J
    Transplant Proc; 2007 Dec; 39(10):3436-7. PubMed ID: 18089400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of CTLA4-Ig gene modified dendritic cell on Th1/Th2 balance in vitro].
    Ying LY; Fu Z; Luo J; Chen Y; Liu EM; Wang LJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):266-9. PubMed ID: 21419045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
    Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ
    J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenoreactive CD4+ memory T cells resist inhibition by anti-CD44 mAb and reject islet grafts via a Th2-dependent pathway.
    Peng Y; Chen J; Shao W; Wang F; Dai H; Cheng P; Xia J; Wang F; Huang R; Zhu Q; Qi Z
    Xenotransplantation; 2011; 18(4):252-61. PubMed ID: 21848543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.